Financhill
Buy
58

LMAT Quote, Financials, Valuation and Earnings

Last price:
$91.28
Seasonality move :
2.06%
Day range:
$90.61 - $93.60
52-week range:
$52.88 - $109.58
Dividend yield:
0.7%
P/E ratio:
50.34x
P/S ratio:
9.79x
P/B ratio:
6.26x
Volume:
435.2K
Avg. volume:
180.3K
1-year change:
67.97%
Market cap:
$2.1B
Revenue:
$193.5M
EPS (TTM):
$1.83

Earnings Data

Next earnings date for LMAT
Feb 27
2025
Most recent earnings per share
$0.49
Beat by $0.06
(Oct 31/2024)
Consensus Estimate
$0.43
(Oct 31/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LMAT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/27/2025 Q4 $56M -- -- $0.49 --
10/31/2024 Q3 $53.5M $54.8M $0.49 $0.43 $0.06
08/01/2024 Q2 $55M $55.8M $0.52 $0.47 $0.05
05/02/2024 Q1 $51.5M $53.5M $0.44 $0.39 $0.05
02/27/2024 Q4 $49M $48.9M $0.38 $0.36 $0.03
11/01/2023 Q3 -- -- $0.33 $0.30 $0.03
08/01/2023 Q2 -- -- $0.36 $0.32 $0.04
05/02/2023 Q1 -- -- $0.27 $0.25 $0.02
02/23/2023 Q4 -- -- $0.25 $0.26 -$0.01
10/27/2022 Q3 -- -- $0.25 $0.28 -$0.03
07/28/2022 Q2 -- -- $0.16 $0.30 -$0.14
04/28/2022 Q1 -- -- $0.27 $0.28 -$0.01
02/24/2022 Q4 -- -- $0.28 $0.31 -$0.03
10/28/2021 Q3 -- -- $0.30 $0.33 -$0.03
07/29/2021 Q2 -- -- $0.40 $0.36 $0.04
04/29/2021 Q1 -- -- $0.28 $0.27 $0.01
02/25/2021 Q4 -- -- $0.34 $0.29 $0.05
10/29/2020 Q3 -- -- $0.37 $0.19 $0.18
07/23/2020 Q2 -- -- $0.17 $0.01 $0.16
04/30/2020 Q1 -- -- $0.16 $0.16 $0.00
02/06/2020 Q4 -- -- $0.23 $0.23 $0.00
10/23/2019 Q3 -- -- $0.25 $0.21 $0.04
07/24/2019 Q2 -- -- $0.23 $0.21 $0.02
05/01/2019 Q1 -- -- $0.17 $0.19 -$0.02
02/19/2019 Q4 -- -- $0.30 -- --
10/04/2018 Q3 -- -- $0.21 -- --
07/26/2018 Q2 -- -- $0.43 -- --
04/25/2018 Q1 -- -- $0.19 -- --
02/21/2018 Q4 -- -- $0.21 -- --
10/26/2017 Q3 -- -- $0.25 -- --
07/27/2017 Q2 -- -- $0.23 -- --
04/26/2017 Q1 -- -- $0.16 -- --
02/21/2017 Q4 -- -- $0.13 -- --
10/26/2016 Q3 -- -- $0.17 -- --
07/27/2016 Q2 -- -- $0.14 -- --
05/02/2016 Q1 -- -- $0.11 -- --
02/24/2016 Q4 -- -- $0.13 -- --
10/27/2015 Q3 -- -- $0.11 -- --
07/28/2015 Q2 -- -- $0.10 -- --
04/28/2015 Q1 -- -- $0.08 -- --
02/25/2015 Q4 -- -- $0.11 -- --

LeMaitre Vascular Earnings Questions

  • How Much did LeMaitre Vascular Generate in Revenue Last Quarter?

    LeMaitre Vascular reported $54.8M worth of top line sales in its most recent quarter.

  • Did LeMaitre Vascular Beat Earnings Last Quarter?

    LeMaitre Vascular announced earnings per share of $0.49 which represents a beat of analyst forecast a $0.43 per share.

  • Is LeMaitre Vascular Profitable?

    LeMaitre Vascular reported $37.2M that represents $1.63 per share over the last quarter.

  • What is the Analyst Consensus for LeMaitre Vascular EPS Next Year?

    LeMaitre Vascular's earnings are forecast to grow from $1.34 per share to $1.33 per share next year representing an increase of 44.78%.

  • When is LeMaitre Vascular's Earnings Date?

    LeMaitre Vascular's next earnings date is February 27, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 1.14% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 4.03% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.44% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock